Glycolipid entries from the LIPID MAPS Structure Database (LMSD).
Database | Last Updated |
---|---|
ChEBI | February 3, 2022 |
KEGG | February 3, 2022 |
LIPID MAPS Structure Database | February 3, 2022 |
LipidBank | February 3, 2022 |
PubChem | February 3, 2022 |
Main Class | Sub Class | LM ID | Common Name | Systematic Name | LipidBank ID | KEGG ID | PubChem CID | ChEBI ID | Exact Mass | Formula ▲ |
---|---|---|---|---|---|---|---|---|---|---|
Acidic glycosphingolipids
|
Gangliosides
|
GalNAc-GD1a(d18:1/26:1(17Z))
|
GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
|
2150.161005
|
C100H175N5O44
|
|||||
Acidic glycosphingolipids
|
Gangliosides
|
GalNAc-GD1a(Neu5Ac/Neu5Gc)(d18:1/26:1(17Z))
|
GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
|
2166.15592
|
C100H175N5O45
|
|||||
Acidic glycosphingolipids
|
Gangliosides
|
GalNAc-GD1a(Neu5Gc/Neu5Ac)(d18:1/26:1(17Z))
|
GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
|
2166.15592
|
C100H175N5O45
|
|||||
Acidic glycosphingolipids
|
Gangliosides
|
NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
|
2230.13558
|
C100H175N5O49
|
||||||
Acidic glycosphingolipids
|
Gangliosides
|
NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0)
|
2262.12541
|
C100H175N5O51
|
||||||
Acidic glycosphingolipids
|
Gangliosides
|
Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
2201.145416
|
C100H176N4O48
|
||||||
Acidic glycosphingolipids
|
Gangliosides
|
Galalpha1-3Galalpha1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
2217.140331
|
C100H176N4O49
|
||||||
Neutral glycosphingolipids
|
Galb1-3GlcNAcb1-3Galb1-4Glc- (Lacto series)
|
Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(Fucalpha1-2Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
|
2249.130161
|
C100H176N4O51
|
||||||
Neutral glycosphingolipids
|
Galb1-3GlcNAcb1-3Galb1-4Glc- (Lacto series)
|
Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
|
2249.130161
|
C100H176N4O51
|
||||||
Neutral glycosphingolipids
|
Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series)
|
Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
|
2249.130161
|
C100H176N4O51
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01